Maurits Huigen has a background in mathematics, informatics, and business administration and build a 20-year career in the pharmaceutical industry taking up national, pan-European leadership roles in large, midsize, and small pharmaceutical companies. He has run his consultancy firm where he advices, supports and/or invests in, either foreign or local companies in the med-tech and pharmaceutical industry. Currently Maurits is CEO of start-up company Gilbert, with a mission to redefine treatment for patients with lung diseases.